|
FIND (Foundation for Innovative New Diagnostics) is a not-for-profit foundation whose aim is to provide innovative and affordable diagnostic products for all levels of the health care system in developing countries. FIND's main function lies in creating sustainable partnerships and providing the necessary expertise, capacity and facilities needed to drive the R&D process. Most importantly, they ensure that the diagnostic technologies developed with their partners are made available in high burden countries. Following WHO endorsement, they work with partners in order to collect evidence for scale-up and to support the widespread implementation of these tools. The Foundation does not own manufacturing facilities, clinical trial sites, reference laboratories or laboratories for quality control, has no capabilities for storage of biological reference materials and is not involved in any marketing and sales beyond the initial negotiating of price reductions for co-developed technologies. The design, development, manufacture, evaluation and demonstration of these tools are achieved entirely through their trial site partners, in collaboration with industry.〔()〕 FIND headquarters are located in Geneva (Switzerland), with offices in Kampala (Uganda) and New Delhi (India). In 2011, FIND was recognized as an “Other International Organization” by the Swiss Government, alongside DNDi and Medicines for Malaria Venture. ==History== FIND was founded at the 56th World Health Assembly in 2003, with an initial five-year grant from the Bill & Melinda Gates Foundation.〔()〕 Launched at a meeting of the World Health Assembly in 2003, FIND was created in order to bring diagnostic solutions to the very societies where treatable diseases are rampant and where poverty and poor health are closely intertwined. With an initial five-year grant from the Bill & Melinda Gates Foundation, FIND set out to develop diagnostic approaches that have been proven in principle and to transform them into effective products for identifying TB – in partnership with academia, public and private research institutes and industry. In 2011, FIND’s Board approved a further expansion of focus to other diseases – such as HIV/AIDS, leishmaniasis and Chagas disease – in instances where there is a clear link to existing disease programmes and technological platforms. In 2006, FIND also started working on strengthening laboratories in disease-endemic countries, and working with partners to roll-out FIND-developed technologies. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Foundation for Innovative New Diagnostics」の詳細全文を読む スポンサード リンク
|